The study has shown free radical processes during modeling of Parkinson Disease (PD) with rotenone. We isolated striatum, brainstem, neocortex, cerebellum, spinal cord, thymus, heart, and liver of rats after rotenone injection in the right striatum. The samples were taken on the 5th, 10th and 15th days after the injection. According to chemiluminescence data, the injection of rotenone initiates the disturbance of intensity of free radical processes in striatum at 5th day in a bilateral mode. After this until the 10th day these changes had restoring character, but after 15 days according to chemiluminescence and thio-barbituric acid test disturbance of lipid peroxide oxidation processes occurred. While superoxide dismutase activity has been changed significantly in all studied tissues, especially in the striatum and neocortex. It should be noted that during rotenone model there are no observed clinical symptoms in rats during 1 to 20 days, and the symptoms of the disease are observed approximately 28 days after the injection. This research could help diagnose PD in the early stage of its onset.
Cannon, J. and Greenamyre, J. (2010) Neurotoxic in Vivo Models of Parkinson’s Disease Recent Advances. Progress in Brain Research, 184, 17-33. http://dx.doi.org/10.1016/S0079-6123(10)84002-6
Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) Alpha-Synuclein in Lewy Bodies. Nature, 388, 839-840. http://dx.doi.org/10.1038/42166
Sherer, T.B., Betarbet, R. and Greenamyre, J.T. (2002) Environment, Mitochondria, and Parkinson’s Disease. Neuroscientist, 8, 192-197.
Lang, A.E. and Lozano, A.M. (1998) Parkinson’s Disease. First of Two Parts. New England Journal of Medicine, 339, 1044-1053. http://dx.doi.org/10.1056/NEJM199810083391506
Vernon, G., Carty, A., Salemno, C., Siskind, M. and Thomas, C. (2014) Understanding Parkinson Disease: An Evolving Case Study. Nurse Practitioner, 39, 1-10. http://dx.doi.org/10.1097/01.NPR.0000453646.44157.83
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A.R., Bioulac, B., Brotchie, J.M. and Gross, C.E. (2001) Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson’s Disease. Journal of Neuroscience, 21, 6853-6861.
Xiong, N., Xiong, J., Jia, M., Liu, L., Zhang, X., Chen, Z., Huang, J., Zhang, Z., Hou, L., Luo, Z., Ghoorah, D., Lin, Z. and Wang, T. (2013) The Role of Autophagy in Parkinson’s Disease: Rotenone-Based Modeling. Behavioral and Brain Functions, 9, 1-12. http://dx.doi.org/10.1186/1744-9081-9-13
Bove, J., Prov, D., Perier, C. and Przedborski, S. (2005) Toxin-Induced Models of Parkinsons Disease. Neuro Rx, 3, 484-494. http://dx.doi.org/10.1602/neurorx.2.3.484
Garcia-Garcia, F., Ponce, S., Brown, R. and Cussen, V. (2005) Sleep Distarbances in the Rotenone Animal Model of Parkinson Disease. Brain Research, 2, 160. http://dx.doi.org/10.1016/j.brainres.2005.02.036
Papov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T. and Greenamyre, J.T. (2005) Rotenone Model of Parkinson Disease Multiple Brain Mitochondria Dysfunctions after Short Term Systemic Rotenone Intoxication. Journal of Biological Chemistry, 280, 42026-42035. http://dx.doi.org/10.1074/jbc.M508628200
Sherer, T.B., Richardson, J.R., Testa, C.M., Seo, B.B., Panov, A.V., Yagi, T., Matsuno-Yagi, A., Miller, G.W. and Greenamyre, J.T. (2007) Mechanism of Toxicity of Pesticides Acting at Complex I: Relevance to Environmental Etiologies of Parkinson’s Disease. Journal of Neurochemistry, 100, 1469-1479. http://dx.doi.org/10.1111/j.1471-4159.2006.04333.x
Cancela, J., Pastorino, M., Tzallas, A., Tsipouras, M., Rigas, G., Arredondo, M. and Wearability, F.D. (2014) Assessment of a Wearable System for Parkinson’s Disease Remote Monitoring Based on a Body Area Network of Sensors. Sensors, 14, 17235-17255. http://dx.doi.org/10.3390/s140917235
Miyasaki, J., Al Hassan, K., Lang, A. and Voon, V. (2007) Punding Prevalence in Parkinson’s Disease. Movement Disorders, 22, 1179-1181. http://dx.doi.org/10.1002/mds.21296
Mulcahy, P., O’Doherty, A., Paucard, A., O’Brien, T., Kirik, D. and Dowd, E. (2012) Development and Characterisation of a Novel Rat Model of Parkinson’s Disease Induced by Sequential Intranigral Administration of AAV-α-Synuclein and the Pesticide, Rotenone. Neuroscience, 203, 170-179. http://dx.doi.org/10.1016/j.neuroscience.2011.12.011
Dexter, D.T. and Jenner, P. (2013) Parkinson Disease: From Pathology to Molecular Disease Mechanisms. Free Radical Biology & Medicine, 62, 132-144. http://dx.doi.org/10.1016/j.freeradbiomed.2013.01.018
Przedborski, S. and Ischiropoulos, H. (2005) Reactive Oxygen and Nitrogen Species Weapons of Neuronal Destruction in Models of Parkinson’s Disease. Antioxidants & Redox Signaling, 7, 685-693. http://dx.doi.org/10.1089/ars.2005.7.685
Paxinos, G. and Watson, C. (2005) The Rat Brain in Stereotaxic Coordinates. Compact 6th Edition, Academic Press, New York, 400.
Ayvazian, N.M., Zakharian, A.E. and Karageuzyan, K.G. (2002) Intensity of Lipid’s Free-Radical Oxidation Processes and Superoxid Dismutase’s Activity in Nervous Tissue of Vertebrates. Neurochemistry, 4, 278-284.
Zaqaryan, A.E., Elbakyan, V.L. and Ayvazyan, N.M. (2006) The Bases of ChL-Analysis Methodology and LABVIEW Program for Registration and Mathematical Processing of Data. Proceedings of the Conference on Educational, Scientific and Engendering Application in LABVIEW Media and National Instruments Technology, Moscow, 17-18 November 2006, 429-432.
Stalnaja, I.D. and Garishvili, T.G. (1985) Method of Malonic Dialdehide Determination with Thiobarbituroacid. In: Biokhimicheskiemetodiissledovania (Biochemical Methods of Investigations), 66-68. (In Russian)
Lowry, O.H., Resenbrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein Measurement with the Folin Phenol Reagent. The Journal of Biological Chemistry, 193, 265-275.
Betarbet, R. and Greenamyre, J. (2007) Parkinson’s Disease: Animal Models. Handbook of Clinical Neurology, 83, 265-287. http://dx.doi.org/10.1016/S0072-9752(07)83011-9
Kuranuki, S., Arai, C., Terada, S., Aoyama, T. and Nakamura, T. (2011) Possible Regulatory Factors for Intra-Abdominal Fat Mass in a Rat Model of Parkinson’s Disease. Nutrition, 27, 239-243. http://dx.doi.org/10.1016/j.nut.2009.12.002
Ferro, M., Angelucci, M., Anselmo-Franci, J., Canteras, N. and Da Cunha, C. (2007) Neuroprotective Effect of Ketamine/Xylazine on Two Rat Models of Parkinson’s Disease. Brazilian Journal of Medical and Biological Research, 40, 89-96. http://dx.doi.org/10.1590/S0100-879X2007000100012
Mignon, L. and Wolf, W. (2007) Postsynaptic 5-HT1A Receptor Stimulation Increases Motor Activity in the 6-Hydroxydopamine-Lesioned Rat: Implications for Treating Parkinson’s Disease. Psychopharmacology, 192, 49-59. http://dx.doi.org/10.1007/s00213-006-0680-0
Morris, J., Zhang, H., Gupte, A., Bomhoff, G., Stanford, J. and Geiger, P. (2008) Measures of Striatal Insulin Resistance in a 6-Hydroxydopamine Model of Parkinson’s Disease. Brain Research, 1240, 185-195. http://dx.doi.org/10.1016/j.brainres.2008.08.089
Sousa, S.C., Macicl, E.N., Vercesi, A.E. and Castilho, R.F. (2003) Ca2+-Induced Oxidative Stress in Brain Mitochondria Treated with the Respiratory Chain Inhibitor Rotenone. FEBS Letters, 543, 179-183. http://dx.doi.org/10.1016/S0014-5793(03)00421-6